Brain Fog, Joint Pain and Sleep: How to Address Soft Indications for MHT

How do we treat women who come with many symptoms of menopause, but not the FDA-recognized indications? What other indications do we have data on, such as T2DM prevention in high risk women, and how do we counsel on this? We will discuss those topics and take your questions in this 60-minute webinar.

June 18, 2025

Speakers: Dr. Yashika Dooley Dr. Wendy Satmary

5:00 PM Pacific | 6:00 PM Mountain | 7:00 PM Central | 8:00 PM Eastern

> Register for this webinar

MHT and Long-Term Risks in Older Menopausal Patients

“Lowest dose for shortest time” is the line we used for the last generation of women on MHT, but is that data driven or reactionary? What evidence do we have for long-term use of MHT and safety? When to stop? Does it impact dementia risk? We will discuss those topics and take your questions in this 60-minute webinar.

July 16, 2025

5:00 PM Pacific | 6:00 PM Mountain | 7:00 PM Central | 8:00 PM Eastern

> Register for this webinar